send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
Type your modal answer and submitt for approval
At the first summit of the leaders of the Quadrilateral grouping, a Quad vaccine initiative was announced Friday in which India will manufacture American vaccines with Japanese funding and Australian logistical support for countries in the Indo-Pacific region.
These were among the concrete outcomes after Prime Minister Narendra Modi, US President Joe Biden, Japan PM –1--and Australian PM Scott Morrison met via virtual mode for the first summit of the grouping.
‘The Quad Vaccine Partnership: A factsheet’ issued after the summit stated: “While ensuring that vaccines have been made available to our people, “Quad” partners will launch a landmark partnership to further accelerate the end of the Covid-19 pandemic. Together, Quad leaders are taking shared action necessary to expand safe and effective Covid-19 vaccine manufacturing in 2021, and will work together to strengthen and assist countries in the Indo-Pacific with vaccination, in close coordination with the existing relevant multilateral mechanisms including WHO and COVAX.”
It said the US will work with Biological E Ltd to finance increased capacity to support Biological E’s effort to produce at least 1 billion doses of Covid-19 vaccines by the end of 2022 with Stringent Regulatory Authorization and/or World Health Organization Emergency Use Listing (EUL), including the Johnson & Johnson vaccine.
Which of the following is not correctly matched?
AstraZeneca vaccine – UK
Sinovac – China
Pfizer - the US
Novavax- Australia
The Novavax COVID-19 vaccine, codenamed NVX-CoV2373, and also called SARS-CoV-2 rS (recombinant spike) protein nano particle with Matrix-M1 adjuvant, is a COVID-19 vaccine candidate developed by Novavax and Coalition for Epidemic Preparedness Innovations (CEPI). It requires two doses and is stable at 2 to 8 °C (36 to 46 °F) (refrigerated).
By: Parvesh Mehta ProfileResourcesReport error
Access to prime resources
New Courses